All News #Library
Rare Diseases
Remepy Collaborates With Merck KGaA To Advance Hybrid Drugs
28 Apr 2026 //
PR NEWSWIRE
FDA Accepts Pimicotinib NDA For Tenosynovial Giant Cell Tumor
12 Jan 2026 //
BUSINESSWIRE
EMD Serono Innovates Rare Neuromuscular Disorder Treatment
24 Nov 2025 //
BUSINESSWIRE
European Commission grants approval of Ogsiveo
18 Aug 2025 //
PRESS RELEASE
Merck KGaA plans China submission after win for tumor drug
12 Nov 2024 //
ENDPTS

Market Place
Sourcing Support